Core Insights - The company attributes its 2025 progress to the 'Three-S' strategy (Simplify, Streamline, Strengthen), which has stabilized the store brand business and improved infant formula service levels above 90% [1] - Performance was driven by significant market share gains in U.S. OTC and European brands, despite a soft market characterized by reduced consumer consumption and a shift to smaller units [1] - The company secured over $100 million in new distribution and competitive takeaways, marking a reversal of years of share decline [1] - Operational results benefited from $320 million in advantages from Project Energize and supply chain reinvention, which helped offset gross profit flow-through headwinds [1] - Management is focusing on 'CORE Perrigo' by divesting non-core assets like Dermacosmetics to concentrate on high-scale consumer health categories [1] - The current market weakness is viewed as 90% transitory, attributed to a lack of historical price increases and a weak cough and cold season rather than structural shifts [1]